Gault Cheryl: insider trades.
Gault Cheryl reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($416K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Gault Cheryl
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | Officer · Chief Operating Officer | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Rapport Therapeutics, Inc. | S | 1,000 | $43.15 | 149,914 | Form 4 |
| 2026-06-30 | Rapport Therapeutics, Inc. | S | 3,308 | $42.17 | 150,914 | Form 4 |
| 2026-06-30 | Rapport Therapeutics, Inc. | S | 1,900 | $40.09 | 158,014 | Form 4 |
| 2026-06-30 | Rapport Therapeutics, Inc. | S | 3,792 | $41.39 | 154,222 | Form 4 |
Questions
What stock did Gault Cheryl buy or sell?
Gault Cheryl reported 4 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($416K), across 1 company.
Is Gault Cheryl the same person as other filers with this name?
This page covers SEC CIK 1839046 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/gault-cheryl-1839046.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.